Tema Obesity & Cardiometabolic ETF Rating $29.71 +0.22 (+0.75%) As of 03:08 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Tema Obesity & Cardiometabolic ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.80Holdings in HRTS have an aggregate rating of Moderate Buy based on 628 analyst ratings issued in the past year covering 37 companies (82.8% of the portfolio).HRTS Aggregate Price Target$29.71High Prediction$29.71Average Prediction$29.71Low Prediction$29.71Holdings in HRTS have an aggregate price target of $29.71 and a range of $29.71 to $29.71 covering 37 companies (82.8% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Obesity & Cardiometabolic ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.66%LLYEli Lilly and Company$822.26-0.2%4.5008 of 5 stars2.85$1,009.72 22.8%205.23%UNHUnitedHealth Group$481.18-1.0%4.9893 of 5 stars3.05$629.32 30.8%22Analyst RevisionPositive News3.95%BBIOBridgeBio Pharma$32.59+0.8%4.488 of 5 stars2.92$51.55 58.2%123.79%ABTAbbott Laboratories$130.29-1.8%4.8553 of 5 stars2.84$137.94 5.9%19Analyst ForecastPositive News3.72%RHHBYRoche$43.56+3.7%N/A2.506Short Interest ↑News CoverageGap Up3.61%VRTXVertex Pharmaceuticals$495.42+1.4%3.8214 of 5 stars2.65$506.70 2.3%26Analyst UpgradeInsider TradePositive News3.34%MRKMerck & Co., Inc.$93.44-1.4%5 of 5 stars2.65$117.12 25.3%23Short Interest ↑3.09%TMOThermo Fisher Scientific$512.94-0.2%4.8606 of 5 stars2.82$653.23 27.3%22Insider TradePositive News2.96%MDTMedtronic$91.58-1.8%4.3794 of 5 stars2.44$96.07 4.9%16Dividend AnnouncementPositive News2.93%BSXBoston Scientific$96.42+0.9%4.543 of 5 stars3.00$108.91 13.0%23Positive NewsGap Up2.73%GILDGilead Sciences$113.99-0.4%4.4135 of 5 stars2.72$104.52 -8.3%29Analyst ForecastPositive News2.70%AMGNAmgen$312.50-2.0%4.0388 of 5 stars2.46$314.04 0.5%24Analyst RevisionPositive NewsGap Down2.52%ABBVAbbVie$211.80-0.8%4.6641 of 5 stars2.88$211.45 -0.2%24Positive News2.18%CRNXCrinetics Pharmaceuticals$35.40+3.3%4.195 of 5 stars2.92$72.64 105.2%131.96%DHRDanaher$205.24-0.2%4.9203 of 5 stars2.71$278.00 35.5%21Short Interest ↑Positive News1.93%CYTKCytokinetics$43.99-0.9%4.3264 of 5 stars2.94$82.00 86.4%181.93%BMYBristol-Myers Squibb$59.83-2.7%4.3411 of 5 stars2.32$57.86 -3.3%19Short Interest ↑Analyst RevisionPositive News1.90%REGNRegeneron Pharmaceuticals$689.50-4.0%4.6695 of 5 stars2.76$973.13 41.1%25Short Interest ↑1.89%EWEdwards Lifesciences$68.52+0.2%4.7793 of 5 stars2.42$79.95 16.7%26Insider TradeShort Interest ↓Positive News1.83%DXCMDexCom$70.76+0.7%4.8548 of 5 stars2.94$99.82 41.1%18Insider TradeAnalyst RevisionGap Down1.76%PODDInsulet$248.38+1.2%4.2491 of 5 stars2.82$292.06 17.6%17Short Interest ↑1.70%ALNYAlnylam Pharmaceuticals$242.43+1.5%4.8321 of 5 stars2.72$304.26 25.5%25Analyst ForecastShort Interest ↓Analyst Revision1.56%MCKMcKesson$640.93-1.9%4.5576 of 5 stars2.93$645.79 0.8%15Positive News1.49%ASNDAscendis Pharma A/S$150.31+3.2%3.0103 of 5 stars2.93$202.36 34.6%141.35%MASIMasimo$167.67+0.7%3.1799 of 5 stars2.83$194.80 16.2%6Gap Up1.22%MDGLMadrigal Pharmaceuticals$327.31-2.4%3.9518 of 5 stars2.85$375.75 14.8%13Gap Up1.00%MREOMereo BioPharma Group$2.54+1.2%2.8423 of 5 stars3.43$7.83 208.4%7News CoveragePositive News0.90%ARWRArrowhead Pharmaceuticals$15.77+4.7%3.6806 of 5 stars2.60$41.44 162.8%100.90%AKROAkero Therapeutics$45.85+4.6%4.1003 of 5 stars3.00$76.29 66.4%9Insider TradeGap Down0.90%INSMInsmed$74.04+0.5%4.1147 of 5 stars3.00$93.33 26.1%160.88%RCKTRocket Pharmaceuticals$8.80+7.2%4.6706 of 5 stars2.92$43.00 388.6%12Analyst ForecastGap UpHigh Trading Volume0.86%MIRMMirum Pharmaceuticals$45.03+2.2%4.1253 of 5 stars3.09$58.20 29.2%11Positive News0.84%IONSIonis Pharmaceuticals$33.41+1.2%4.3094 of 5 stars2.70$59.56 78.3%20Analyst Forecast0.82%GPCRStructure Therapeutics$21.42+4.3%2.0822 of 5 stars3.00$81.29 279.5%8Gap UpHigh Trading Volume0.81%WSTWest Pharmaceutical Services$224.23-2.8%4.8134 of 5 stars2.83$344.00 53.4%6Analyst Revision0.63%VKTXViking Therapeutics$29.55+11.4%4.4136 of 5 stars3.00$96.31 225.9%14Analyst ForecastNews CoverageGap Up0.33%NTLAIntellia Therapeutics$9.62+3.4%4.4628 of 5 stars2.63$37.56 290.4%19 This page (NYSEARCA:HRTS) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
